Welcome to the Investor Relations section of the GW Pharmaceuticals website.
This area is dedicated to keeping shareholders and potential investors up to date with share price, news and other relevant information.
- 0.23 (-0.19%)
12/12/2017 - 4:00 PM
Dec 11, 2017
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriter's Option to Purchase Additional ADSs
Dec 6, 2017
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $276 Million